Transient Expression of GATA3 in Hematopoietic Stem Cells Facilitates Helper Innate Lymphoid Cell Differentiation.
GATA3
HSCs
differentiation
electroporation
helper ILCs
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2019
2019
Historique:
received:
15
11
2018
accepted:
26
02
2019
entrez:
6
4
2019
pubmed:
6
4
2019
medline:
4
9
2020
Statut:
epublish
Résumé
Helper Innate lymphoid cells (ILCs) are tissue resident lymphocytes that play a critical role in a number of biological processes. Several transcription factors are required for the differentiation of hematopoietic stem cells (HSCs) into ILCs. Recent studies demonstrate GATA3 as a transcriptional regulator that plays an essential role in ILC development. We aimed to modulate the differentiation of human cord blood-derived CD34
Identifiants
pubmed: 30949172
doi: 10.3389/fimmu.2019.00510
pmc: PMC6438154
doi:
Substances chimiques
GATA3 Transcription Factor
0
GATA3 protein, human
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
510Subventions
Organisme : NCI NIH HHS
ID : P30 CA046934
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI100879
Pays : United States
Références
Immunity. 2003 Dec;19(6):863-75
pubmed: 14670303
Blood. 2006 Dec 1;108(12):3824-33
pubmed: 16902150
Nature. 2009 Feb 5;457(7230):722-5
pubmed: 18978771
J Exp Med. 2009 Jan 16;206(1):35-41
pubmed: 19114665
Bioinformatics. 2010 Apr 1;26(7):873-81
pubmed: 20147302
Nature. 2010 Apr 29;464(7293):1367-70
pubmed: 20200518
Nat Biotechnol. 2010 May;28(5):511-5
pubmed: 20436464
Immunol Rev. 2010 Nov;238(1):93-109
pubmed: 20969587
Blood. 2011 Apr 14;117(15):4052-5
pubmed: 21310921
Nat Immunol. 2011 Sep 11;12(11):1055-62
pubmed: 21909091
Nat Immunol. 2011 Sep 11;12(10):949-58
pubmed: 21909092
Science. 2012 Apr 6;336(6077):91-5
pubmed: 22383805
J Exp Med. 2012 Apr 9;209(4):729-40
pubmed: 22430492
Immunity. 2012 Aug 24;37(2):339-50
pubmed: 22921121
Immunity. 2012 Oct 19;37(4):649-59
pubmed: 23063330
Immunity. 2012 Oct 19;37(4):634-48
pubmed: 23063333
Blood. 2013 Mar 21;121(12):2234-43
pubmed: 23327921
Nature. 2013 Feb 14;494(7436):261-5
pubmed: 23334414
Nat Immunol. 2013 Mar;14(3):221-9
pubmed: 23334791
Immunity. 2013 Apr 18;38(4):769-81
pubmed: 23453631
Proc Natl Acad Sci U S A. 2013 Jun 18;110(25):10240-5
pubmed: 23733962
J Exp Med. 2014 Feb 10;211(2):199-208
pubmed: 24419270
Nature. 2014 Apr 17;508(7496):397-401
pubmed: 24509713
J Virol. 2014 May;88(10):5877-80
pubmed: 24600007
Immunity. 2014 Mar 20;40(3):378-88
pubmed: 24631153
Cell. 2014 Apr 10;157(2):340-356
pubmed: 24725403
Blood. 2014 Jul 31;124(5):812-21
pubmed: 24855210
Immunity. 2014 Sep 18;41(3):354-365
pubmed: 25238093
Immunity. 2014 Dec 18;41(6):988-1000
pubmed: 25500367
Cell Rep. 2015 Mar 31;10(12):2043-54
pubmed: 25801035
Nat Immunol. 2015 Jun;16(6):599-608
pubmed: 25915732
J Exp Med. 2015 Jun 1;212(6):875-82
pubmed: 25964370
Nat Rev Immunol. 2015 Jul;15(7):415-28
pubmed: 26065585
Nat Commun. 2015 Sep 23;6:8280
pubmed: 26395069
Nature. 2015 Dec 24;528(7583):560-564
pubmed: 26649819
Curr Opin Immunol. 2016 Feb;38:75-85
pubmed: 26707651
Cell Rep. 2016 Oct 4;17(2):436-447
pubmed: 27705792
Cell. 2017 Mar 9;168(6):1086-1100.e10
pubmed: 28283063
J Clin Invest. 2017 May 1;127(5):1813-1825
pubmed: 28375154
Front Immunol. 2017 Mar 27;8:360
pubmed: 28396671
Blood. 2017 Jun 29;129(26):3428-3439
pubmed: 28533309
Front Immunol. 2017 Aug 31;8:1047
pubmed: 28912776
J Exp Med. 2018 Jan 2;215(1):249-262
pubmed: 29183988
Front Immunol. 2017 Nov 14;8:1571
pubmed: 29184556
Cell. 2018 Aug 23;174(5):1054-1066
pubmed: 30142344